Investigating the Histological Changes in Heart, Lung, Liver and Kidney of Male Albino Mice Treated with Ivabradine

Investigating the Histological Changes in Heart, Lung, Liver and Kidney of Male Albino Mice Treated with Ivabradine

The present study aimed to investigate the histological changes of heart, lung, liver and kidney which caused by different concentrations (10, 20 and 40 mg/kg) of Ivabradine. Results of the study revealed some histological changes represented by aggregation of the lymphocytes around respiratory bron...

Full description

Bibliographic Details
Main Author:	Hadeel Kamil Khaleel
Format:	Article
Language:	Arabic
Published:	College of Science for Women, University of Baghdad 2019-09-01
Series:	Baghdad Science Journal
Subjects:	Histological changes, Ivabradine, Kidney, Liver, Lung
Online Access:	http://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/4129

Similar Items

ROLE OF HEART RATE REDUCTION WITH IVABRADINE IN LEFT VENTRICULAR FAILURE IVABRADINE AND HEART RATE REDUCTION IN LEFT VENTRICULAR FAILURE
by: Safia Batool, et al.
Published: (2020-12-01)

Effect of doxorubicin on the histological structure of the kidneys in male albino rats
by: Wasan W. Al-Hassawi, et al.
Published: (2014-01-01)

Ivabradine in Chronic Heart Failure
by: Hadeer Eid, et al.
Published: (2020-06-01)

Efficacy and safety evaluation of ivabradine in patients with non-ischemic heart failure
by: LIU Ying-xian, SONG Yan-jun, CHEN Wei, LIN Xue, LAI Jin-zhi, LI Jing-yi, WU Wei
Published: (2021-11-01)

Histological and Physiological Study of Kidney in Adult Male Albino Mice Mus musculus
by: Bushra O. Maaroof, et al.
Published: (2017-03-01)

Ivabradine therapy and correction of the target organ pathology in patients with ischemic chronic heart failure
by: M. V. Surovtseva, et al.
Published: (2013-06-01)

Evaluation of ivabradine in left ventricular dyssynchrony and reverse remodeling in patients with chronic heart failure
by: Korhan Soylu, et al.
Published: (2020-08-01)

Observational study of new-onset atrial fibrillation in patients treated with Ivabradine alone versus Ivabradine and β-blocker drug (The BetaBrad Study)
by: Rohan S Thanedar, et al.
Published: (2022-01-01)

Efficacy of ivabradine in idiopathic dilated cardiomyopathy patients with chronic heart failure
by: Sherief Mansour, et al.
Published: (2011-06-01)

Ivabradine Ameliorates Kidney Fibrosis in L-NAME-Induced Hypertension
by: Peter Stanko, et al.
Published: (2020-07-01)

ROLE OF HEART RATE REDUCTION WITH IVABRADINE IN LEFT VENTRICULAR FAILURE
by: Safia Batool, et al.
Published: (2020-12-01)

Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction
by: Ying‐Hsiang Lee, et al.
Published: (2021-04-01)

Effect of ivabradine on heart rate, functional capacity and pulmonary artery pressure in patients of COPD with cor pulmonale
by: Mohammad Kaleem, et al.
Published: (2021-05-01)

Ivabradine Prevents Heart Rate Acceleration in Patients with Chronic Obstructive Pulmonary Disease and Coronary Heart Disease after Salbutamol Inhalation
by: Uta C. Hoppe, et al.
Published: (2012-04-01)

IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
by: P. Kh. Dzhanashiya, et al.
Published: (2010-02-01)

Histological and Biochemical Changes in the Liver of Albino Mice on Exposure to Insecticide, Carbosulfan
by: Kaliwal, B.B., et al.
Published: (2006-10-01)

The Biological Effects of Ivabradine in Cardiovascular Disease
by: Graziano Riccioni, et al.
Published: (2012-04-01)

Mid cristal atrial tachycardia and ivabradine: A Case Report
by: Debasish Das, et al.
Published: (2021-01-01)

EFFICACY OF IVABRADINE AND VERAPAMIL IN PATIENTS WITH DIASTOLIC HEART FAILURE CAUSED BY LEFT VENTRICLE IMPAIRED RELAXATION
by: K. G. Adamyan, et al.
Published: (2016-01-01)

IVABRADINE THERAPY IN PATIENTS WITH CORONARY HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: N. A. Zheleznyakova, et al.
Published: (2012-02-01)

Short-term effects of ivabradine in patients with chronic stable ischemic heart disease
by: Hosam Zaky, et al.
Published: (2013-01-01)

The effect of ivabradine on hospitalization of heart failure patients: A retrospective cohort study
by: Sara Al-Balushi, et al.
Published: (2021-01-01)

The possibilities of usage of ivabradin (Coraxan) in elderly and senile patients with the syndrome of polymorbidity
by: A. N Ilnitskij, et al.
Published: (2013-12-01)

IVABRADINE OUTSIDE THE CLINICAL GUIDELINES: INTEREST OF A PRACTITIONER
by: E. I. Tarlovskaya
Published: (2018-04-01)

The role of heart rate and ivabradine in acute heart failure
by: Edoardo Sciatti, et al.
Published: (2019-10-01)

Effect glucosamine sulfate drug on liver tissue of male Albino mice
by: Baghdad Science Journal
Published: (2015-06-01)

Effect of Ivabradine in Controlling Heart Rate in Patients with Sepsis and Septic Shock: Randomized Control Trails
by: S. M. Muneeb Ali, et al.
Published: (2023-03-01)

Effectiveness and safety of ivabradine in Chinese patients with chronic heart failure: an observational study
by: Jingmin Zhou, et al.
Published: (2024-04-01)

Evaluation of Clinical outcomes of Generic versus Reference Ivabradine in Heart Failure Patients
by: Hadeer Eid, et al.
Published: (2020-12-01)

Epidemiologic surveillance on quality of life in patients with systolic heart failure after treatment with the selective heart rate inhibitor ivabradine
by: M Srinivasa Rao, et al.
Published: (2017-01-01)

IVABRADINE IN PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION: NEW DATA FROM THE SHIFT MULTICENTER RANDOMIZED TRIAL
by: S. N. Tereshchenko, et al.
Published: (2016-08-01)

Comparison between ivabradine and low-dose digoxin in the therapy of diastolic heart failure with preserved left ventricular systolic function
by: Giuseppe Cocco, et al.
Published: (2013-11-01)

Advances in the management of heart failure: the role of ivabradine
by: Müller-Werdan U, et al.
Published: (2016-11-01)

DYNAMICS OF HEART RATE VARIABILITY AND VENTRICULAR ECTOPIC ACTIVITY IN IVABRADINE-TREATED PATIENTS WITH CHRONIC HEART FAILURE
by: M. V. Surovtseva, et al.
Published: (2012-12-01)

PR Interval as a Novel Therapeutic Target of Ivabradine Therapy—Prognostic Impact of Ivabradine-Induced PR Prolongation in Heart Failure Patients
by: Riona Yamamoto, et al.
Published: (2024-01-01)

Initiation of ivabradine in cardiogenic shock
by: Michael H. Chiu, et al.
Published: (2019-10-01)

IF CHANNEL INHIBITOR IVABRADINE AND CHRONIC HEART FAILURE MANAGEMENT: FROM DISCUSSION TO ACTION
by: Yu. M. Lopatin
Published: (2012-08-01)

Physiological and histological effects of broccoli on lead acetate Induced hepatotoxicity in young Male albino rats
by: Sulaf Mohammed, et al.
Published: (2019-03-01)

Ivabradine in patients with heart failure: a systematic literature review
by: Zeba M. Khan, et al.
Published: (2023-12-01)

The myocardial remodeling at ischemic chronic heart failure: the features of Ivabradine influence in experimental model
by: S. V. Fedorov, et al.
Published: (2016-12-01)